PneumoBlast (fibroblast cell therapy) / Fibrogenesis - LARVOL DELTA

Clinical and evolving specificities of bronchopulmonary cancer in young patients in the Tunisian Center region (CPLF 2023) - "The histological aspect was dominated by pulmonary adenocarcinoma (61.9%), epidermoid carcinoma (19%), CPC (9.5%) with 1 case of pulmonary pneumoblastoma and 1 case of muco-epidermoid carcinoma...Conclusion The incidence of this cancer in young adults becomes a major public health concern. This population must be the target of prevention campaigns."

Clinical • Cough • Hodgkin Lymphoma • Lung Adenocarcinoma • Lung Cancer • Oncology • Pain • Respiratory Diseases • Solid Tumor • Squamous Cell Carcinoma

FibroGenesis Reports Positive Preclinical Data in Pancreatic and Breast Cancer Using "Universal Acting" Fibroblast Based Immunotherapy (PRNewswire) - “FibroGenesis…announced today new data supporting utilizing its fibroblast-based immunotherapy for successful inhibition and induction of regression in preclinical models of breast cancer and pancreatic cancer. Company scientists successfully replicated the process by which cancer coaxes fibroblasts to support its growth.”

Preclinical • Breast Cancer • Gastrointestinal Cancer • Oncology • Pancreatic Cancer

FibroGenesis Expands Fight Against COVID-19 In Brazil with International Collaboration (PRNewswire) - "FibroGenesis...has entered into a clinical collaboration agreement with Brazilian R4D Biotech....FibroGenesis is expanding its ongoing clinical programs internationally. The partnership will pave the way for clinical studies of PneumoBlast™ in Brazil....PneumoBlast™ has induced statistically significant reduction of lung fibrosis and lung scarring in COVID-19 infected animals....Recent data supports the potential benefits of PneumoBlast™ for preventing COVID-19 blood clotting. Both companies will collaborate on a clinical study design..."

Licensing / partnership • New trial • Preclinical • Infectious Disease • Novel Coronavirus Disease